"FiercePharmaManufacturing" reports that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled its generic version of anti-depressant Cymbalta, duloxetine, because of a customer complaint about capsule breakage. The voluntary total recall totals one million bottles.
Brand Cymbalta, made by Eli Lilly & Co. (NYSE: LLY), had $5.4 billion in annual US sales. Teva began marketing its generic version of the drug in the fourth quarter of 2012.
Teva produces generic Cymbalta at its plant in Jerusalem.
"The safety and efficacy of our medicines is one of Teva's top priorities. We recalled all impacted lots (19) and have identified and remediated the root cause of this recall. This has no material impact on the company," said Teva in a statement to "FiercePharma".
"FiercePharmaManufacturing" also reports Teva is also voluntarily recalling nearly 258,000 cylinders of its inhaled asthma drug Qvar, after it failed stability testing for impurity and degradation specifications at both the 9-month and 18-month time periods. According to the recall notice, the product is manufactured for Teva by California-based 3M Drug Delivery Systems.
Qvar had $328 million in US sales in 2013, up 10.4% over 2012, according to the company's F-20 annual statement filing with the US Securities and Exchange Commission (SEC).
Published by Globes [online], Israel business news - www.globes-online.com - on April 16, 2014
© Copyright of Globes Publisher Itonut (1983) Ltd. 2014